Paul Jung

2PUBLICATIONS
14CO-AUTHORS
Gene and molecular therapyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Dec 18, 2025
The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma.

Kaiting Jiang, Marieluise Kirchner, Frederik Herzberg

|Nov 26, 2025
The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma.

Kaiting Jiang, Marieluise Kirchner, Frederik Herzberg

Pageof 1